Aliskiren Hemifumarate
Specifications
173334-58-2CAS Number
630-415-8EC Number
bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acidIUPAC Name
C64H110N6O16Chemical Formula
1219.6 g/molMolecular Weight
Aliskiren hemifumarate; 173334-58-2; Aliskiren fumarate; Enviage; Riprazo; Sprimeo; Rasilez; SPP-100B; C8A0P8G029; NSC-759185; CHEBI:53777; RASILAMLO COMPONENT ALISKIREN HEMIFUMARATE; RASITRIO COMPONENT ALISKIREN HEMIFUMARATE; VALTURNA COMPONENT ALISKIREN HEMIFUMARATE; RAPRAZO-HCT COMPONENT ALISKIREN HEMIFUMARATE; RASILEZ-HCT COMPONENT ALISKIREN HEMIFUMARATE; SPRIMEO-HCT COMPONENT ALISKIREN HEMIFUMARATE; DTXSID601026205; RefChem:56249; DTXCID601510456; Bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methyl-2-(1-methylethyl)nonanamide) (2E)-but-2-enedioate; Tekturna; Aliskiren (hemifumarate); (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;(E)-but-2-enedioic acid; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide hemifumarate; Benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphaS,gammaS,deltaS,zetaS)-, (2E)-2-butenedioate (2:1); CGP60536B; C64H110N6O16; Aliskiren fumarate [USAN]; UNII-C8A0P8G029; Aliskiren fumarate [USAN:JAN]; Tekturna (TN); Bis(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methyl-2-(1-methylethyl)nonanamide) (2E)-but-2-enedioate; Bis(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(1-methylethyl)nonanamide] (2E)-but-2-enedioate; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxo-propyl)-4-hydroxy-2-isopropyl-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-nonanamide;fumaric acid; SCHEMBL187762; orb1225938; orb1308348; ALISKIREN (AS FUMARATE); Aliskiren fumarate (JAN/USAN); ALISKIREN FUMARATE [JAN]; CHEMBL3545059; SCHEMBL29382912; CGP 60536 (hemifumarate);CGP60536B (hemifumarate);SPP 100 (hemifumarate); KLRSDBSKUSSCGU-KRQUFFFQSA-N; CGP-60536B; GLXC-07080; ALISKIREN FUMARATE [MART.]; ALISKIREN HEMIFUMARATE [MI]; ALISKIREN FUMARATE [WHO-DD]; EBC-15050; s2199; ALISKIREN HEMIFUMARATE [VANDF]; AKOS015896419; CCG-270658; CS-0729; FA17280; KS-1395; NSC 759185; s12129; BA164146; DA-50324; DA-60912; HY-12177; Aliskiren hemifumarate - Bio-X trade mark; ALISKIREN HEMIFUMARATE [ORANGE BOOK]; A4534; SW222231-1; D06412; EN300-122378; TEKAMLO COMPONENT ALISKIREN HEMIFUMARATE; AMTURNIDE COMPONENT ALISKIREN HEMIFUMARATE; F813780; TEKTURNA HCT COMPONENT ALISKIREN HEMIFUMARATE; Q27124205; Z1541759907; (2E)-but-2-enedioic acid; bis((2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide); (a-S,gamma-S,?S,zS)-?-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-a,z-bis(1-methylethyl) benzeneoctanamide hemifumarate; Benzeneoctanamide, |A-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-|A-hydroxy-4-methoxy-3-(3-methoxypropoxy)-|A,|AE-bis(1-methylethyl)-, (|AS,|AS,|AS,|AES)-, (2E)-2-butenedioate (2:1); Benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphaS,gammaS,deltaS,zetaS)-, (2E)-2-butenedioate (2:1) (salt); bis((2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide); but-2-enedioic acid; bis{(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide} (2E)-but-2-enedioateSynonyms
